Dougherty Wealth Advisers’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
Dougherty Wealth Advisers's PFE Position: Q1 2021 in Review
Dougherty Wealth Advisers sold out of Pfizer (PFE) in Q1 2021, closing a stake of 1,230 shares — an estimated $45K sold.
Dougherty Wealth Advisers first reported a position in PFE in Q4 2018 and held it in 9 quarters. The position peaked at $110K in Q2 2019. 2,675 funds tracked by Wall St. Rank hold PFE as of Q1 2021.
- Dougherty Wealth Advisers reported no remaining Pfizer position as of Q1 2021 after selling out during the quarter.
- Dougherty Wealth Advisers sold 1,230 Pfizer shares in Q1 2021, an estimated $45K.
- Dougherty Wealth Advisers first reported a position in Pfizer in Q4 2018 and held it in 9 quarters.
- Dougherty Wealth Advisers's Pfizer position peaked at $110K in Q2 2019.
- 2,675 funds tracked by Wall St. Rank held Pfizer as of Q1 2021.
Based on Dougherty Wealth Advisers's 13F filing for Q1 2021, filed 6 May 2021.